Advertisement
Screener

AMARIN CORP PLC\UK (AMRN) Earnings Per Share (Basic)

2.8 / 5 stars · 68/120 Roast Me

AMARIN CORP PLC\UK Earnings Per Share (Basic)

AMARIN CORP PLC\UK (AMRN) reported Earnings Per Share (Basic) of -$0.02 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:EarningsPerShareBasic · last filed 2026-07-29

  • AMARIN CORP PLC\UK earnings per share, basic for the quarter ending 2026-06-30 was -$0.02.
  • AMARIN CORP PLC\UK earnings per share, basic for the quarter ending 2026-03-31 was -$0.03.
  • AMARIN CORP PLC\UK earnings per share, basic for the quarter ending 2025-12-31 was -$0.00.
  • AMARIN CORP PLC\UK earnings per share, basic for the quarter ending 2025-09-30 was -$0.02.
  • AMARIN CORP PLC\UK earnings per share, basic for fiscal 2025 was -$0.09.
  • AMARIN CORP PLC\UK earnings per share, basic for fiscal 2024 was -$0.20.
  • AMARIN CORP PLC\UK earnings per share, basic for fiscal 2023 was -$0.15.
  • AMARIN CORP PLC\UK earnings per share, basic for fiscal 2022 was -$0.26, a 1400.00% decline from fiscal 2021.
Period endEarnings Per Share, Basic 3 monthEarnings Per Share, Basic 6 monthEarnings Per Share, Basic 9 monthEarnings Per Share, Basic 12 month
2026-06-30-$0.02
10-Q · filed 2026-07-29
-$0.04
10-Q · filed 2026-07-29
-$0.05
derived: net income ÷ weighted average shares · filed 2026-07-29
-$0.07
derived: net income ÷ weighted average shares · filed 2026-07-29
2026-03-31-$0.03
10-Q · filed 2026-04-29
-$0.03
derived: net income ÷ weighted average shares · filed 2026-04-29
-$0.05
derived: net income ÷ weighted average shares · filed 2026-04-29
-$0.08
derived: net income ÷ weighted average shares · filed 2026-07-29
2025-12-31-$0.00
derived: net income ÷ weighted average shares · filed 2026-03-02
-$0.02
derived: net income ÷ weighted average shares · filed 2026-03-02
-$0.06
derived: net income ÷ weighted average shares · filed 2026-07-29
-$0.09
10-K · filed 2026-03-02
2025-09-30-$0.02
10-Q · filed 2025-10-29
-$0.05
derived: net income ÷ weighted average shares · filed 2026-07-29
-$0.09
10-Q · filed 2025-10-29
-$0.21
derived: net income ÷ weighted average shares · filed 2026-07-29
2025-06-30-$0.03
10-Q · filed 2026-07-29
-$0.07
10-Q · filed 2026-07-29
-$0.19
derived: net income ÷ weighted average shares · filed 2026-07-29
-$0.25
derived: net income ÷ weighted average shares · filed 2026-07-29
2025-03-31-$0.04
10-Q · filed 2026-04-29
-$0.16
derived: net income ÷ weighted average shares · filed 2026-04-29
-$0.22
derived: net income ÷ weighted average shares · filed 2026-04-29
-$0.21
derived: net income ÷ weighted average shares · filed 2026-04-29
2024-12-31-$0.12
derived: net income ÷ weighted average shares · filed 2026-03-02
-$0.18
derived: net income ÷ weighted average shares · filed 2026-03-02
-$0.18
derived: net income ÷ weighted average shares · filed 2026-03-02
-$0.20
10-K · filed 2026-03-02
2024-09-30-$0.06
10-Q · filed 2025-10-29
-$0.06
derived: net income ÷ weighted average shares · filed 2025-10-29
-$0.08
10-Q · filed 2025-10-29
-$0.10
derived: net income ÷ weighted average shares · filed 2026-03-02
2024-06-30$0.00
10-Q · filed 2025-07-30
-$0.02
10-Q · filed 2025-07-30
-$0.03
derived: net income ÷ weighted average shares · filed 2026-03-02
-$0.08
derived: net income ÷ weighted average shares · filed 2026-03-02
2024-03-31-$0.02
10-Q · filed 2025-05-07
-$0.04
derived: net income ÷ weighted average shares · filed 2026-03-02
-$0.09
derived: net income ÷ weighted average shares · filed 2026-03-02
-$0.13
derived: net income ÷ weighted average shares · filed 2026-03-02
2023-12-31-$0.01
derived: net income ÷ weighted average shares · filed 2026-03-02
-$0.06
derived: net income ÷ weighted average shares · filed 2026-03-02
-$0.10
derived: net income ÷ weighted average shares · filed 2026-03-02
-$0.15
10-K · filed 2026-03-02
2023-09-30-$0.05
10-Q · filed 2024-10-30
-$0.09
derived: net income ÷ weighted average shares · filed 2024-10-30
-$0.13
10-Q · filed 2024-10-30
-$0.13
derived: net income ÷ weighted average shares · filed 2025-03-12
2023-06-30-$0.04
10-Q · filed 2024-07-31
-$0.08
10-Q · filed 2024-07-31
-$0.08
derived: net income ÷ weighted average shares · filed 2025-03-12
-$0.09
derived: net income ÷ weighted average shares · filed 2025-03-12
2023-03-31-$0.04
10-Q · filed 2024-05-01
-$0.04
derived: net income ÷ weighted average shares · filed 2025-03-12
-$0.05
derived: net income ÷ weighted average shares · filed 2025-03-12
2022-12-31$0.00
derived: net income ÷ weighted average shares · filed 2025-03-12
-$0.01
derived: net income ÷ weighted average shares · filed 2025-03-12
-$0.26
10-K · filed 2025-03-12
2022-09-30-$0.01
10-Q · filed 2023-11-01
-$0.27
10-Q · filed 2023-11-01
2022-06-30-$0.18
10-Q · filed 2023-08-02
-$0.26
10-Q · filed 2023-08-02
2022-03-31-$0.08
10-Q · filed 2023-05-03
2021-12-31$0.02
10-K · filed 2024-02-29
2021-09-30-$0.03
10-Q · filed 2022-10-27
-$0.02
10-Q · filed 2022-10-27
2021-06-30$0.02
10-Q · filed 2022-08-03
$0.02
10-Q · filed 2022-08-03
2021-03-31$0.00
10-Q · filed 2022-05-04
2020-12-31-$0.05
10-K · filed 2023-03-01
2020-09-30-$0.02
10-Q · filed 2021-11-03
-$0.06
10-Q · filed 2021-11-03
2020-06-30$0.01
10-Q · filed 2021-08-05
-$0.04
10-Q · filed 2021-08-05
2020-03-31-$0.06
10-Q · filed 2021-04-29
2019-12-31$0.02
10-K · filed 2020-02-25
-$0.07
10-K · filed 2022-03-01
2019-09-30-$0.01
10-Q · filed 2020-11-05
-$0.09
10-Q · filed 2020-11-05
2019-06-30-$0.01
10-Q · filed 2020-08-04
-$0.08
10-Q · filed 2020-08-04
2019-03-31-$0.07
10-Q · filed 2020-04-30
2018-12-31-$0.11
10-K · filed 2020-02-25
-$0.39
10-K · filed 2021-02-25
2018-09-30-$0.08
10-K · filed 2020-02-25
-$0.28
10-Q · filed 2019-11-05
2018-06-30-$0.12
10-K · filed 2020-02-25
-$0.20
10-Q · filed 2019-07-31
2018-03-31-$0.08
10-K · filed 2020-02-25
2017-12-31-$0.08
10-K · filed 2019-02-27
-$0.25
10-K · filed 2020-02-25
2017-09-30-$0.04
10-K · filed 2019-02-27
-$0.17
10-Q · filed 2018-11-01
2017-06-30-$0.05
10-K · filed 2019-02-27
-$0.13
10-Q · filed 2018-08-01
2017-03-31-$0.08
10-K · filed 2019-02-27
2016-12-31-$0.10
10-K · filed 2018-02-27
-$0.18
derived: net income ÷ weighted average shares · filed 2019-02-27
-$0.26
derived: net income ÷ weighted average shares · filed 2019-02-27
-$0.41
10-K · filed 2019-02-27
2016-09-30-$0.08
10-K · filed 2018-02-27
-$0.15
derived: net income ÷ weighted average shares · filed 2017-11-01
-$0.31
10-Q · filed 2017-11-01
-$0.42
derived: net income ÷ weighted average shares · filed 2018-02-27
2016-06-30-$0.07
10-K · filed 2018-02-27
-$0.23
10-Q · filed 2017-08-02
-$0.35
derived: net income ÷ weighted average shares · filed 2018-02-27
-$0.53
derived: net income ÷ weighted average shares · filed 2018-02-27
2016-03-31-$0.16
10-K · filed 2018-02-27
-$0.28
derived: net income ÷ weighted average shares · filed 2018-02-27
-$0.46
derived: net income ÷ weighted average shares · filed 2018-02-27
-$0.80
derived: net income ÷ weighted average shares · filed 2018-02-27
2015-12-31-$0.12
10-K · filed 2017-03-01
-$0.30
derived: net income ÷ weighted average shares · filed 2018-02-27
-$0.64
derived: net income ÷ weighted average shares · filed 2018-02-27
-$0.83
10-K · filed 2018-02-27
2015-09-30-$0.18
10-K · filed 2017-03-01
-$0.52
derived: net income ÷ weighted average shares · filed 2016-11-03
-$0.71
10-Q · filed 2016-11-03
-$0.82
derived: net income ÷ weighted average shares · filed 2017-03-01
2015-06-30-$0.35
10-K · filed 2017-03-01
-$0.53
10-Q · filed 2016-08-04
-$0.65
derived: net income ÷ weighted average shares · filed 2017-03-01
-$0.80
derived: net income ÷ weighted average shares · filed 2017-03-01
2015-03-31-$0.18
10-K · filed 2017-03-01
-$0.29
derived: net income ÷ weighted average shares · filed 2017-03-01
-$0.44
derived: net income ÷ weighted average shares · filed 2017-03-01
-$0.36
derived: net income ÷ weighted average shares · filed 2017-03-01
2014-12-31-$0.11
10-K · filed 2016-02-25
-$0.26
derived: net income ÷ weighted average shares · filed 2017-03-01
-$0.17
derived: net income ÷ weighted average shares · filed 2017-03-01
-$0.32
10-K · filed 2017-03-01
2014-09-30-$0.15
10-K · filed 2016-02-25
-$0.06
derived: net income ÷ weighted average shares · filed 2015-11-04
-$0.21
10-Q · filed 2015-11-04
-$0.30
derived: net income ÷ weighted average shares · filed 2016-02-25
2014-06-30$0.09
10-K · filed 2016-02-25
-$0.06
10-Q · filed 2015-08-06
-$0.15
derived: net income ÷ weighted average shares · filed 2016-02-25
-$0.44
derived: net income ÷ weighted average shares · filed 2016-02-25
2014-03-31-$0.15
10-K · filed 2016-02-25
-$0.24
derived: net income ÷ weighted average shares · filed 2016-02-25
-$0.53
derived: net income ÷ weighted average shares · filed 2016-02-25
-$0.78
derived: net income ÷ weighted average shares · filed 2016-02-25
2013-12-31-$0.09
10-K · filed 2015-03-03
-$0.37
derived: net income ÷ weighted average shares · filed 2016-02-25
-$0.63
derived: net income ÷ weighted average shares · filed 2016-02-25
-$1.03
10-K · filed 2016-02-25
2013-09-30-$0.29
10-K · filed 2015-03-03
-$0.55
derived: net income ÷ weighted average shares · filed 2014-11-06
-$0.96
10-Q · filed 2014-11-06
2013-06-30-$0.26
10-K · filed 2015-03-03
-$0.68
10-Q · filed 2014-08-07
2013-03-31-$0.41
10-K · filed 2015-03-03
2012-12-31-$0.07
10-K · filed 2013-02-28
-$1.24
10-K · filed 2015-03-03
2012-09-30-$0.18
10-K · filed 2013-02-28
-$1.19
10-Q · filed 2012-11-08
2012-06-30-$0.38
10-K · filed 2013-02-28
2012-03-31-$0.65
10-K · filed 2013-02-28
2011-12-31$0.14
10-K · filed 2013-02-28
-$0.53
10-K · filed 2014-02-27
2011-09-30$0.72
10-K · filed 2013-02-28
-$0.68
10-Q · filed 2012-11-08
2011-06-30-$1.58
10-K · filed 2013-02-28
2011-03-31$0.15
10-K · filed 2013-02-28
2010-09-30-$0.11
10-Q · filed 2011-11-08
-$0.62
10-Q · filed 2011-11-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
Processa Pharmaceuticals, Inc. (PCSA)United States$0.005B
Dermata Therapeutics, Inc. (DRMA)United States$0.005B-0.62
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)United States$0.005B
Xenetic Biosciences, Inc. (XBIO)United States$0.006B
ProPhase Labs, Inc. (PRPH)United States$0.006B-0.06
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90
Lakewood-Amedex Biotherapeutics Inc. (LABT)United States$0.004B
Pulmatrix, Inc. (PULM)United States$0.006B
60 DEGREES PHARMACEUTICALS, INC. (SXTP)United States$0.004B-0.59
Ernexa Therapeutics Inc. (ERNA)United States$0.006B